Home Monsanto Making Do, But It's M&A That Everyone Seems To Want
 

Keywords :   


Monsanto Making Do, But It's M&A That Everyone Seems To Want

2016-01-08 02:01:40| Chemicals - Topix.net

Monsanto has a full R&D pipeline, but it's M&A that has everyone's attention - Syngenta is probably the best target, but Bayer and BASF are at least possible options. With a fair value around $105, shareholders can afford to be patient with Monsanto but a real upward move needs a healthier ag market or a positive M&A announcement.

Tags: to that want making

Category:Chemicals

Latest from this category

All news

18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
17.05Dutch Boy Paints Introduces Professional Series at Menards
17.05RadTech 2024 Sustainability Award Winners are Selected
17.05BYK-Gardner USA Launches New Dispermat Dissolver CV3evo
17.05BASF Ranks 22 on Fair360 list of Top 50 Companies for Diversity
17.05Nisar Amin Named Regional Sales Manager at JNS-SmithChem
17.05PNWSCT Coatings Fest 2024 Issues Call for Papers
16.05BASF Expands Biomass Balance Portfolio for Selected Chemical Intermediates
Chemicals »
19.05Cashing In On The Stache
19.05 Dr. Squatch Launches Bronco Bricc
19.05Gillette Venus Announces Ambassadors Ahead of the Olympic and Paralympic Games Paris 2024
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05'I had no choice but to get a 35-year mortgage'
More »